New guidelines have been released on how to combat the sexual health disorder erectile dysfunction (ED).
The document was put together from the results of 130 trials which tested oral phosphodiesterase (PDE-5) inhibitors alone or mixed with another type.
Sexual performance using this type of treatment was successful in a significant number of cases and as a result physicians have been informed that it should be the first part of patient's therapy.
Dr Amir Qaseem, a senior medical associate at the American College of Physicians, which published the guidelines, commented that patients were at liberty to decide what type of PDE-5 treatment they could afford or prefer.
"The evidence is insufficient to compare the effectiveness or adverse effects of different PDE-5 inhibitors for the treatment of ED because there were only a few head-to-head trials," continued Dr Qaseem.
Recent research at the Children's Hospital Boston indicated that employing a short questionnaire called CRAFFT in medical facilities could help to identify young people with potential sexual health problems by finding out if they are involved in substance or alcohol abuse.